Abstract:Rare diseases are usually chronically debilitating or even life-threatening with diagnostic and therapeutic challenges in current clinical practice. It has been estimated that 80% of rare diseases are genetic in origin, and thus genome sequencing-based diagnosis offers a promising alternative for rare-disease management. In this study, 79 individuals from 16 independent families were performed for whole-genome sequencing (WGS) in an effort to identify the causative mutations for 16 distinct rare diseases that are largely clinically intractable. Comprehensive analysis of variations, including simple nucleotide variants (SNVs), copy-number variations (CNVs), and structural variations (SVs), was implemented using the WGS data. A flexible analysis pipeline that allowed a certain degree of misclassification of disease status was developed to facilitate the identification of causative variants. As a result, disease-causing variants were identified in 10 of the 16 investigated diseases, yielding a diagnostic rate of 62.5%. Additionally, new potentially pathogenic variants were discovered for two disorders, including IGF2/INS-IGF2 in mitochondrial disease and FBN3 in Klippel–Trenaunay–Weber syndrome. Our WGS analysis not only detected a CNV associated with 3p deletion syndrome but also captured a simple sequence repeat (SSR) variation associated with Machado–Joseph disease. To our knowledge, this is the first time the clinical WGS analysis of short-read sequences has been used successfully to identify a causative SSR variation that perfectly segregates with a repeat expansion disorder. After the WGS analysis, we confirmed the initial diagnosis for three of 10 established disorders and modified or corrected the initial diagnosis for the remaining seven disorders. In summary, clinical WGS is a powerful tool for the diagnosis of rare diseases, and its diagnostic clarity at molecular levels offers important benefits for the participating families.

Identification of diagnostic candidates in Mendelian disorders using an RNA sequencing-centric approach

Clinical validation of RNA sequencing for Mendelian disorder diagnostics

Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease

Mapping RNA splicing variations in clinically accessible and nonaccessible tissues to facilitate Mendelian disease diagnosis using RNA-seq

Analysis of transcript-deleterious variants in Mendelian disorders: implications for RNA-based diagnostics

Improving Genetic Diagnosis of Mendelian Disease with RNA Sequencing: a Narrative Review

Systematic evaluation of the two main blood-based RNA-seq approaches for Mendelian disease diagnosis

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Application of RNA Sequencing in Clinical Diagnosis of Mendelian Disease

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Identification of synonymous pathogenic variants in monogenic disorders by integrating exome with transcriptome sequencing

Assessing the diagnostic impact of blood transcriptome profiling in a pediatric cohort previously assessed by genome sequencing

Leveraging Splice-Affecting Variant Predictors and a Minigene Validation System to Identify Mendelian Disease-Causing Variants among Exon-Captured Variants of Uncertain Significance.

RNA Splicing Analysis Contributes to Reclassifying Variants of Uncertain Significance and Improves the Diagnosis of Monogenic Disorders

Improving genetic diagnosis in Mendelian disease with transcriptome sequencing

RNA variant assessment using transactivation and transdifferentiation

Comparison of in silico strategies to prioritize rare genomic variants impacting RNA splicing for the diagnosis of genomic disorders

RNA Sequencing in Disease Diagnosis

RNA Sequencing Facilitates the Identification of Genetic Causes of Duchenne Muscular Dystrophy and Proposes a Stepwise DMD Diagnostic Procedure

The clinical utility and diagnostic implementation of human subject cell transdifferentiation followed by RNA sequencing

Identification of Deep-Intronic Splice Mutations in a Large Cohort of Patients With Inherited Retinal Diseases